Revolution Medicines, Inc.

This study is testing whether a new oral drug called daraxonrasib works better than standard chemotherapy for people with advanced pancreatic cancer that has spread. The trial involves 501 patients whose cancer has continued to grow despite previous treatment. Researchers will co…